Bulent Dabanlıoglu

5PUBLICATIONS

22CO-AUTHORS

Medical infection agents (incl. prions)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jul 06, 2026

Alternative therapy against CTX-M broad spectrum β-lactamase resistance gene in Klebsiella pneumoniae infection: bee venom and bee venom-derived nanovesicle fraction.

|Jun 09, 2026

Oral microbiota member Neisseria elongata exosomes-Cassia fistula association targets PTEN/AKT/IL10/IL1β/BAX/BCL-2 signaling pathway in pancreatic cancer immunotherapy.

|Apr 30, 2026

Biotechnological application of Escherichia coli outer membrane vesicles for the delivery of Myristica fragrans phytochemicals in pancreatic cancer therapy.

|Feb 19, 2026

Determinate the effects of Arabic gum and Lactobacillus acidophilus on the gut microbiota ALPK1/NFKB/NLRP6 and NLRP2 signaling pathway and virulence gene profile in rats with Campylobacter jejuni exosome application.

Mahmut Ucar, Ozgur Celebi, Demet Celebi

|May 26, 2021

The protective effect of lycopene against oxidative kidney damage associated with combined use of isoniazid and rifampicin in rats.

F Bedir, H Kocaturk, O Turangezli

Pageof 1

Frequent Collaborators

Sumeyye Baser

Demet Celebi

Ozgur Celebi

Ali Taghizadehghalehjoughi

Serkan Yıldırım

Betul Ari

Mustafa Can Guler

Sıdıka Genc

H Kocaturk

S Akyuz

Frequent Collaborators

Sumeyye Baser

Demet Celebi

Ozgur Celebi

Ali Taghizadehghalehjoughi